KK2. the NIH provides funding for trials. That was the thrust of the message. Money is what we are missing. We can be granted all the FDA designations and special meetings in the world but if we have a CEO who can't raise $50 million for a piece of a slam-dunk blockbuster drug (and maybe that times ten over) then nothing else matters.
jmho